{{Rsnum
|rsid=2233406
|Gene=NFKBIA
|Chromosome=14
|position=35405593
|Orientation=minus
|GMAF=0.2277
|Gene_s=NFKBIA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 50.4 | 38.9 | 10.6
| HCB | 75.2 | 21.2 | 3.6
| JPT | 72.3 | 24.1 | 3.6
| YRI | 70.5 | 26.0 | 3.4
| ASW | 44.6 | 44.6 | 10.7
| CHB | 75.2 | 21.2 | 3.6
| CHD | 76.1 | 22.9 | 0.9
| GIH | 49.0 | 41.0 | 10.0
| LWK | 70.0 | 25.5 | 4.5
| MEX | 56.1 | 36.8 | 7.0
| MKK | 68.6 | 29.5 | 1.9
| TSI | 52.5 | 34.7 | 12.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=24368589
|Title=Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis
}}

{{PMID Auto
|PMID=17463416
|Title=IkappaB genetic polymorphisms and invasive pneumococcal disease.
}}

{{PMID Auto
|PMID=19797428
|Title=IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
|OA=1
}}

{{PMID Auto
|PMID=19886988
|Title=Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study.
|OA=1
}}

{{PMID Auto
|PMID=21274447
|Title=Genetic polymorphisms and posttraumatic complications.
|OA=1
}}

{{PMID Auto
|PMID=23487427
|Title=Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia.
}}

{{PMID Auto
|PMID=23996241
|Title=Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer
}}

{{PMID Auto
|PMID=25223483
|Title=Effect of functional nuclear factor kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}